Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma

Clinical trial NCT00945269 · TERMINATED

Trial details

NCT number: NCT00945269
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage III Melanoma Stage IV Melanoma

Start date: 2009-07-01
Primary completion: 2011-01-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.